F-group (family)
101.1.8.3 Topoisom_I,Topo_C_assoc
Ligands and drugs
53
Member domains
8
with ligand contacts (≤ 4 Å)
15.1% of members
9
with DrugDomain annotations
17.0% of members
8
with a DrugBank compound
15.1% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 101.1.8.3 belongs to X-group 101 HTH, which binds 8.7 ligand superclasses per 20 proteins, broader than 73% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB01030 | TTC | Topotecan | 4 |
| DB00762 | — | Irinotecan | 2 |
| DB00970 | — | — | 1 |
| DB00997 | — | Doxorubicin | 1 |
| DB04690 | EHD | Camptothecin | 1 |
| DB04882 | — | — | 1 |
| DB04967 | — | — | 1 |
| DB05129 | — | — | 1 |
| DB05482 | — | SN-38 | 1 |
| DB05630 | — | — | 1 |
| DB05806 | — | — | 1 |
| DB06159 | — | — | 1 |
| DB07354 | AI3 | 2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM | 1 |
| DB08159 | M38 | 4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE | 1 |
| DB11254 | — | — | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| TTG | 2-(1-DIMETHYLAMINOMETHYL-2-HYDROXY-8-HYDROXYMETHYL-9-OXO-9,11-DIHYDRO-INDOLIZINO[1,2-B]QUINOLIN-7-YL)-2-HYDROXY-BUTYRIC ACID | 3 |
| CL | CHLORIDE ION | 2 |
| AI3 | 2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM | 1 |
| EHD | 4-ETHYL-4-HYDROXY-1,12-DIHYDRO-4H-2-OXA-6,12A-DIAZA-DIBENZO[B,H]FLUORENE-3,13-DIONE | 1 |
| HGmetal | MERCURY (II) ION | 1 |
| SA3 | 2,10-DIHYDROXY-12-(BETA-D-GLUCOPYRANOSYL)-6,7,12,13-TETRAHYDROINDOLO[2,3-A]PYRROLO[3,4-C]CARBAZOLE-5,7-DIONE | 1 |
| TTC | (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE | 1 |